Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 05-11-2015 | Practice Area: | Corporate and M&A |
| Deal Title: | Shire Plc Acquisition of Dyax Corp | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May advised Shire Plc on the acquisition of US-based biotechnology company Dyax Corp. for an aggregate upfront consideration of approximately USD5.9 billion.
Under the agreement, Shire would acquire Dyax for USD37.30 per Dyax share. Dyax shareholders could also receive an additional USD4.00 a share, or USD646 million in total, if the US Food and Drug Administration approved the company's leading treatment for HAE, DX-2930.
|
||
| Financial Center: | London | Value: | 5001.00-10000.00 |
| Advised Party: | Acquiror | Law Firm | Slaughter and May |
| Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Public Company - Recommended Offer |
Lawyer | Martin Hattrell |
